430 related articles for article (PubMed ID: 23021687)
21. Fertility-Sparing Treatment of Early Endometrial Cancer and Complex Atypical Hyperplasia in Young Women of Childbearing Potential.
Pronin SM; Novikova OV; Andreeva JY; Novikova EG
Int J Gynecol Cancer; 2015 Jul; 25(6):1010-4. PubMed ID: 25950126
[TBL] [Abstract][Full Text] [Related]
22. Management options and fertility-preserving therapy for premenopausal endometrial hyperplasia and early-stage endometrial cancer.
Gressel GM; Parkash V; Pal L
Int J Gynaecol Obstet; 2015 Dec; 131(3):234-9. PubMed ID: 26384790
[TBL] [Abstract][Full Text] [Related]
23. Fertility preservation in early-stage endometrial cancer and endometrial intraepithelial neoplasia: A single-center experience.
Ayhan A; Tohma YA; Tunc M
Taiwan J Obstet Gynecol; 2020 May; 59(3):415-419. PubMed ID: 32416890
[TBL] [Abstract][Full Text] [Related]
24. The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment.
Song Z; Liu H; Zhou R; Xiao Z; Wang J; Wang H; Lu Q
Arch Gynecol Obstet; 2022 May; 305(5):1215-1223. PubMed ID: 34762188
[TBL] [Abstract][Full Text] [Related]
25. Prolonged conservative treatment in patients with recurrent endometrial cancer after primary fertility-sparing therapy: 15-year experience.
Wang Y; Yu M; Yang JX; Cao DY; Yuan Z; Zhou HM; Zhang Y; Li L; Shen K; Wu H
Int J Clin Oncol; 2019 Jun; 24(6):712-720. PubMed ID: 30746595
[TBL] [Abstract][Full Text] [Related]
26. [Analysis of prognosis and pregnancy outcomes of fertility-preserving treatment for patients with stage Ⅰa, grade 2 endometrial cancer].
Wang YQ; Zhou R; Xu LJ; Xia M; Lu Q; Liu GL; Shen DH; Wang G; He M; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 May; 55(5):327-332. PubMed ID: 32464721
[No Abstract] [Full Text] [Related]
27. Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review.
Gunderson CC; Fader AN; Carson KA; Bristow RE
Gynecol Oncol; 2012 May; 125(2):477-82. PubMed ID: 22245711
[TBL] [Abstract][Full Text] [Related]
28. Pregnancy outcomes using assisted reproductive technology after fertility-preserving therapy in patients with endometrial adenocarcinoma or atypical complex hyperplasia.
Han AR; Kwon YS; Kim DY; Kim JH; Kim YM; Kim YT; Nam JH
Int J Gynecol Cancer; 2009 Jan; 19(1):147-51. PubMed ID: 19258957
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.
Koskas M; Uzan J; Luton D; Rouzier R; Daraï E
Fertil Steril; 2014 Mar; 101(3):785-94. PubMed ID: 24388202
[TBL] [Abstract][Full Text] [Related]
30. [Clinical efficacy and pregnancy outcomes of fertility-preserving re-treatment after recurrence of the patient with atypical endometrial hyperplasia and early stage endometrial carcinoma].
He YJ; Wang YQ; Tang HR; He M; Rao Y; Zhou R; Wang JL
Zhonghua Fu Chan Ke Za Zhi; 2020 Jan; 55(1):21-28. PubMed ID: 32074769
[No Abstract] [Full Text] [Related]
31. Fertility outcomes in infertile women with complex hyperplasia or complex atypical hyperplasia who received progestin therapy and in vitro fertilization.
Li M; Song JL; Zhao Y; Wu SL; Liu HB; Tang R; Yan L
J Zhejiang Univ Sci B; 2017 Nov.; 18(11):1022-1025. PubMed ID: 29119739
[TBL] [Abstract][Full Text] [Related]
32. The influence of infertility treatment on the prognosis of endometrial cancer and atypical complex endometrial hyperplasia.
Ichinose M; Fujimoto A; Osuga Y; Minaguchi T; Kawana K; Yano T; Kozuma S
Int J Gynecol Cancer; 2013 Feb; 23(2):288-93. PubMed ID: 23314282
[TBL] [Abstract][Full Text] [Related]
33. Progression of conservatively treated endometrial complex atypical hyperplasia in a young woman: a case report.
Corrado G; Baiocco E; Carosi M; Vizza E
Fertil Steril; 2008 Nov; 90(5):2006.e5-8. PubMed ID: 18692828
[TBL] [Abstract][Full Text] [Related]
34. [Clinical outcomes analysis of fertility-preserving therapy for atypical endometrial hyperplasia and early endometrial carcinoma].
He YJ; Wang YQ; Dai YB; Zhou R; Lu Q; Liu GL; Wang JL
Zhonghua Zhong Liu Za Zhi; 2022 Mar; 44(3):291-296. PubMed ID: 35316880
[No Abstract] [Full Text] [Related]
35. Management of women with atypical polypoid adenomyoma of the uterus: A quantitative systematic review.
Raffone A; Travaglino A; Saccone G; Alviggi C; Mascolo M; De Placido G; Insabato L; Mollo A; Zullo F
Acta Obstet Gynecol Scand; 2019 Jul; 98(7):842-855. PubMed ID: 30714089
[TBL] [Abstract][Full Text] [Related]
36. Successful pregnancies in 2 infertile patients with endometrial adenocarcinoma.
Nakao Y; Nomiyama M; Kojima K; Matsumoto Y; Yamasaki F; Iwasaka T
Gynecol Obstet Invest; 2004; 58(2):68-71. PubMed ID: 15103232
[TBL] [Abstract][Full Text] [Related]
37. Fertility-sparing therapy in young women with endometrial cancer: 2010 update.
Erkanli S; Ayhan A
Int J Gynecol Cancer; 2010 Oct; 20(7):1170-87. PubMed ID: 21495221
[TBL] [Abstract][Full Text] [Related]
38. Comparison among fertility-sparing therapies for well differentiated early-stage endometrial carcinoma and complex atypical hyperplasia.
Zhang Q; Qi G; Kanis MJ; Dong R; Cui B; Yang X; Kong B
Oncotarget; 2017 Aug; 8(34):57642-57653. PubMed ID: 28915701
[TBL] [Abstract][Full Text] [Related]
39. Conservative treatment may be beneficial for young women with atypical endometrial hyperplasia or endometrial adenocarcinoma.
Jadoul P; Donnez J
Fertil Steril; 2003 Dec; 80(6):1315-24. PubMed ID: 14667859
[TBL] [Abstract][Full Text] [Related]
40. Recurrent endometrial atypical hyperplasia diagnosed by pathological examination of the placenta from a live birth: a case report.
Wu W; Wang W; Zou J
BMC Pregnancy Childbirth; 2023 Sep; 23(1):691. PubMed ID: 37749522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
